Table 10-43Hemiarthroplasty vs total hip replacement - Economic summary of findings

StudyIncremental cost per patient (£)Incremental effectsICERUncertainty
Keating 2005 173£498 (b)Hemiarthroplasty has lower EQ-5D scores at 4, 12 and 24 months (b)NATwo-way sensitivity analysis showed that the direction of change in cost did not change when cost of prostheses and cost of readmission were varied over a range from -50% to +100% around the baseline values.

The mean cost per patient for hemiarthroplasty was 9,897 (95% CI: 8,062 – 11,732) and £9,399 (95% CI: 8,265-10,532) for THR.


Hemiarthroplast had higher number of deaths within 4, 12 and 24 months from operation than THR: 5% vs.4%; 10% vs. 6% and 16% vs. 9%; (p values not significant), but lower reoperation rates at 4, 12 and 24 months: 5% vs. 7%; 5% vs 9%; and 5% vs. 9% (p value NR). THR had higher mean EQ-5D scores at 4, 12 and 24 months: 0.61 vs. 0.68 (not significant); 0.64 vs. 0.70 (not significant); 0.53 vs 0.69 (p=0.008).

From: 10, Surgical procedures

Cover of The Management of Hip Fracture in Adults
The Management of Hip Fracture in Adults [Internet].
NICE Clinical Guidelines, No. 124.
National Clinical Guideline Centre (UK).
Copyright © 2011, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of the National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.